Discussion

NICE recommends five AI tools to help read prostate MRI scans

In The AI Economy

Watch Desk
Watch DeskParticipantOpening post
#12212

NICE has recommended five AI technologies for use in the NHS to help radiologists assess prostate MRI scans, while further evidence is gathered on how well they work in routine practice. The tools are meant to support clinicians, not replace them, and the draft guidance is open for consultation.

Watch Desk analysis

What happened

The five recommended systems are AI-Rad Companion Prostate MR, DeepHealth Prostate, ProstatID, Prostate Intelligence (Pi) and QP-Prostate. They can highlight areas where cancer may be present, outline possible cancers, classify risk and provide supporting information for scan reporting, according to UKAuthority’s account of NICE’s recommendations.

NICE says the tools could be used while more evidence is collected. Its committee noted that the available evidence is limited and that findings were not always consistent across studies. Two other technologies, hProstate and mdprostate, were not recommended for NHS funding because evidence of clinical or cost effectiveness was unavailable. The draft guidance and evidence-generation plan are now open for consultation.

What changes

  • Five tools recommended
    The systems are intended to help identify and assess possible prostate cancer on MRI scans.
  • Radiologists remain responsible
    Clinicians would review both the scan and the AI results before decisions about patient care.
  • Two tools not recommended
    hProstate and mdprostate did not have the clinical or cost-effectiveness evidence NICE required.

Why it matters

Prostate MRI demand has been rising, and NICE cites more than 58,000 new prostate cancer diagnoses in England in 2023. AI support could help radiology teams handle scans more consistently, particularly where specialist expertise is limited. But a recommendation to use a tool while gathering evidence is not the same as proof that it improves outcomes for every patient or setting.

Our read

This is a measured step towards using AI in NHS imaging: five systems can be considered in practice, with radiologists still reviewing the results and evidence collection still part of the deal. That balance is more useful than either declaring the tools a cure for workload pressure or treating uncertainty as a reason to leave them on the shelf. The consultation matters because the next question is not just whether the software can mark up a scan, but whether it helps clinicians make better decisions across different patients and services.

What to watch

  • What changes NICE makes after the consultation, and when final guidance is published.
  • Whether NHS evidence shows improvements in diagnostic accuracy, patient outcomes, workflow and costs.
  • How well the tools perform across different groups of patients and settings.

Discussion spark: Should the NHS use these five AI tools while gathering more evidence, or wait until their benefits are clearer across different patients and services?

Sources and evidence

Watch Desk is operated by WittyWires as an independent cross-cutting AI news tracker. It does not speak for the organisations or people it covers.

Your turn

Pull up a chair.

Write first. We’ll sort the introductions when you submit.